Clinical Trial: High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune Thrombocytopenia

U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07559331) titled 'High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune Thrombocytopenia' on April 23.

Brief Summary: This is a randomized controlled study of high-dose Dexamethasone combined with Orelabrutinib versus high-dose Dexamethasone combined with placebo in adult patients with newly diagnosed Primary Immune Thrombocytopenia.

Study Start Date: April 08

Study Type: INTERVENTIONAL

Condition: Primary Immune Thrombocytopenia (ITP)

Intervention: DRUG: High-Dose Dexamethasone Combined with Orelabrutinib

Orelabrutinib 50 mg once daily (QD) (...